期刊文献+

口服胰岛素聚乳酸纳米粒的胃肠道吸收与药效学研究 被引量:3

Gastrointestinal absorption and pharmacodynamic research of insulin-loaded poly(lactic acid) nanoparticles for oral administration
下载PDF
导出
摘要 目的 考察口服胰岛素聚乳酸纳米粒 (INS PLA NP)在胃肠道不同部位的吸收以及吸收促进剂脱氧胆酸 (DOC)对吸收的影响。方法 在正常大鼠胃肠道不同部位 (胃、小肠、结肠 )分别给予含与不含吸收促进剂DOC的INS PLA NP后 ,观察降血糖效果。结果 大鼠灌胃给药后未能显示降血糖效果 ,添加DOC后仍基本无效。小肠直接给药后表现出和缓持久的降血糖效果 ,而DOC在小肠给药中能明显加快INS PLA NP的吸收并增强药效 ,但这一促进吸收作用存在一定的限度。结肠给药也基本无效 ,添加DOC后可产生强度不大的降血糖作用。结论 INS PLA NP主要在小肠吸收 。 AIM To investigate the effect of DO C(deoxycholic acid) on the absorption of INS-PLA-NP[insulin-loaded poly(lactic acid) nanoparticles] in different sites of gastrointestinal tracts. METHODS After INS-PLA-NP that contained or did not contain DOC was adminitered to different sites in gastrointestianl tracts(stomach, small intestine and colon)of normal rats, the hypoglycemic effect was observed. RESULTS The hypoglycemic effect did not exist after intragastric administration of INS-PLA-NP whether or not DOC was added. The alleviatory hypoglycemic effect was evident after intraintestinal absorption of INS-PLA-NP. After DOC was added, the absorption of INS-PLA-NP was accelerated obviously and the hypoglycemic effect was strengthened significantly. Glucose levels hardly changed after INS-PLA-NP was administered to colon. With the use of DOC, a little hypoglycemic effect appeared. CONCLUSIONS The absorption of INS-PLA-NP in small intestine was accelerated and enhanced by DOC. DOC could be used as absorption enhancer of INS-NP in the future.
出处 《中国药理学通报》 CAS CSCD 北大核心 2003年第8期920-923,共4页 Chinese Pharmacological Bulletin
关键词 脱氧胆酸 胰岛素 聚乳酸 纳米粒 降血糖作用 deoxycholic acid insulin nanoparticles gastrointestinal absorption pharmacodynamics
  • 相关文献

参考文献11

  • 1张强,丁继军,叶国庆,魏树礼.口服胰岛素毫微球的体外释药及对糖尿病大鼠的降血糖作用[J].药学学报,1998,33(2):152-156. 被引量:40
  • 2文爱东,蒋永培.吸收促进剂在口服制剂中增强药物生物利用度的作用[J].国外医学(药学分册),2000,27(6):354-357. 被引量:14
  • 3徐叔云 等.药理实验方法学:第2版[M].人民卫生出版社,1994.1275.
  • 4陈军,易以木,杨希雄,王绪兵.胰岛素聚乳酸纳米粒的初步研究[J].华西药学杂志,2002,17(4):272-273. 被引量:8
  • 5Damge C, Michel C, Aprahamian M et al. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carriers. Diabetes,1988;37(2):246-51.
  • 6Micel C, Appahamian L, Defortaine P et al. The effect of site of administration in the gastrointestinal tract in the absorption of insulin from nanocapsules in diabetic rats. J Pharm Pharmacol,1991;43(1) :1-5.
  • 7Damge C, Vranckx H, Balschmidt P et al. Poly(alkyl cyanoacrylate) nanoparticles for oral administration of insulin. J Pharm Sci, 1997;86(12):1403-9.
  • 8Pimienta C, Chouinard F, Labib A et al. Effect of various Poloxamer coatings on in vitro adhesion of isohexylcyanoacrylate nanospheres to rat ileal segments under liquid flow. Int J Pharm, 1992;80(1):1-8.
  • 9Jani PU, Mccarthy DE, Florence AT. Nanosphere and microsphere uptake via Peyer's patches:Observation of the rate of up-take in the rat after a single oral dose. Int J Pharm,1992;86:239-46.
  • 10Hussain N, Praful U, Horence AT. Enhanced oral uptake of tomato lectin-confugated nanoparticles in the rat. Pharm Res,1997;14(5):613-8.

二级参考文献5

共引文献80

同被引文献13

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部